Tag: chronic myelogenous leukemia therapy

Home / chronic myelogenous leukemia therapy

Categories

Bosutinib is approved by the FDA for pediatric patients with chronic myelogenous leukemia

Nov 2023: For paediatric patients aged one year and above with chronic phase (CP) Ph+ chronic myelogenous leukaemia (CML), either newly diagnosed (ND) or resistant or intolerant (R/I) to previous the...
chronic-myelogenous-leukemia-therapy

Scan the code